SynthesisDiabetes & vascular disease research2017

Effects of aliskiren on mortality, cardiovascular outcomes and adverse events in patients with diabetes and cardiovascular disease or risk: A systematic review and meta-analysis of 13,395 patients.

Sean L Zheng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.